Trial Details 1 Total Sites

A Modular Multi-Basket Trial to Improve Personalized Medicine in Cancer Patients (Basket of Baskets)

The Global objective of this Basket of Basket study is to evaluate the antitumor activity of each matched therapies that will be evaluated through the study in small molecularly selected populations. The objective of module 1 will be to determine the overall response rate by RECIST 1.1 of atezolizumab in several arms. Subjects will be separated into arms depending on the mutations of their tumour. All patients in genomically selected populations will receive atezolizumab 1200 mg IV every 3 weeks

phase

Phase 2

status

Recruiting

enrollment

1000

score

29

start date

2018-12-10

last updated

2021-10-04

biomarkers
Heidelberg, Germany
facility
Deutsches Krebsforschungszentrum (NCT/DKFZ)
1 facility
Recruiting